The Impact of Different Rocuronium Doses on its Pharmacodynamic Profile:a Prospective Study
Authors:
M. Adamus 1; R. Bělohlávek 2; M. Vujčíková 1; E. Janásková 1
Authors‘ workplace:
Klinika anesteziologie a resuscitace, Fakultní nemocnice a Lékařská fakulta Univerzity Palackého, Olomouc 2Katedra matematické informatiky, Přírodovědecká fakulta Univerzity Palackého, Olomouc
1
Published in:
Anest. intenziv. Med., , 2004, č. 6, s. 269-275
Category:
Overview
Objective:
The aim of the study was to assess rocuronium pharmacodynamics following a single bolus dose.Design: Clinical prospective randomized controlled study.Setting: Department of Anaesthesiology and Intensive Care, University Hospital.Material and Methods: Following the ethics committee approval and obtaining informed consent 210 patients scheduled forelective surgery under general anaesthesia with tracheal intubation were randomized into 7 groups with different rocuroniumdoses administered (0.30, 0.45, 0.60, 0.75, 0.90, 1.05, 1.20 mg•kg-1, respectively). After setting up neuromusculartransmission monitoring (Datex-Ohmeda S5 Anaesthesia Monitor with NMT module, ulnar nerve stimulation, TOF pattern,electromyographic evaluation of evoked response of the adductor pollicis muscle), tracheal intubation was performed after80%depression of T1. For each consecutive patient the onset time for 80 (95) % effect, clinical duration and recovery indexwere determined. The recorded data were subjected to statistical analysis.Results: The onset time 80 was 123.3 ± 15.4, 94.7 ± 14.6, 71.3 ± 12.9, 59.2 ± 10.6, 54.7 ± 8.4, 50.8 ± 8.0, 47.0 ± 8.1 seconds,respectively, the onset time 95 was 162.8 ± 14.7, 119.3 ± 13.4, 92.8 ± 13.0, 82.0 ± 16.3, 74.5 ± 13.6, 67.2 ± 12.3, 63.2 ± 9.6seconds. The clinical duration was 15.0 ± 3.7, 23.4 ± 3.8, 35.6 ± 6.1, 45.5 ± 6.6, 53.5 ± 10.5, 62.8 ± 13.1, 70.6 ± 15.0 minutes.The recovery index was 12.5 ± 3.9, 13.3 ± 4.3, 14.9 ± 3.8, 17.9 ± 3.8, 18.5 ± 4.6, 18.8 ± 5.6, 19.9 ± 5.8 minutes. When 80 %depression of T1 was reached the quality of intubating conditions was the same in all groups.Conclusion: Rocuronium is a rapid-onset neuromuscular blocker with a predictable effect. By decreasing the intubatingdose by 50 % the clinical duration is shortened by more than 50 %. If we accept the simultaneous onset time prolongationduring this anaesthetic strategy a low-dose rocuronium can be used for the neuromuscular block of about 15-minuteduration. However, comparable intubating conditions (as assesed from NMT measurements and the clinical picture) arereached after two or more minutes.
Key words:
neuromuscular blocker – rocuronium – onset time – clinical duration – recovery index
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2004 Issue 6
Most read in this issue
- Deaths during Operations and in the Postoperative Period: 155 260 Anaesthetics Administeredin Motol University Hospital Prague during 1999–2003
- Complications of the Percutaneous Dilatational Tracheostomy and Surgical Tracheostomy. AreBoth Methods Equally Safe?
- A Bit of History on Physostigmine and Its Use in Prague
- The Impact of Different Rocuronium Doses on its Pharmacodynamic Profile:a Prospective Study